Brad Kahl
MD
Professor of Medicine
👥Biography 个人简介
Brad Kahl is a senior lymphoma clinician-researcher who has defined treatment timing and rituximab maintenance strategies in follicular lymphoma. His research on watch-and-wait versus early treatment and bendamustine-rituximab regimens has shaped clinical practice. He contributes to clinical trial design that addresses practical management questions in FL.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Brad Kahl 的研究动态
Follow Brad Kahl's research updates
留下邮箱，当我们发布与 Brad Kahl（Washington University School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment